Funding for this research was provided by:
Sanofi China
Article History
Received: 29 July 2020
Accepted: 5 October 2020
First Online: 17 October 2020
Compliance with ethical standards
:
: Chaoyun Li is an employee of Sanofi China; Pei Wang has received the research grant from Sanofi China.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the the Clinical Trial Ethics Committee of the Third Ailiated Hospital, Sun Yat-sen University (Reference Number [2015] 2–152 on 21 July 2015) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all participants at the time of data collection.
: Qualified researchers may request access to patient-level data and related study documents including the clinical study report, study protocol with any amendments, blank case report form, statistical analysis plan, and dataset specifications. Patient-level data will be anonymized, and study documents will be redacted to protect the privacy of trial participants. Further details on Sanofi’s data-sharing criteria, eligible studies, and process for requesting access can be found at: ‘ExternalRef removed.’